Pacific Sun Financial Corp cut its stake in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,485 shares of the company’s stock after selling 325 shares during the period. Pacific Sun Financial Corp’s holdings in Invesco Dynamic Biotechnology & Genome ETF were worth $497,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ibex Wealth Advisors acquired a new position in Invesco Dynamic Biotechnology & Genome ETF in the 2nd quarter valued at $61,000. NEXT Financial Group Inc raised its holdings in Invesco Dynamic Biotechnology & Genome ETF by 14.1% in the 2nd quarter. NEXT Financial Group Inc now owns 2,738 shares of the company’s stock valued at $147,000 after acquiring an additional 338 shares in the last quarter. BB&T Securities LLC raised its holdings in Invesco Dynamic Biotechnology & Genome ETF by 13.2% in the 3rd quarter. BB&T Securities LLC now owns 5,545 shares of the company’s stock valued at $261,000 after acquiring an additional 645 shares in the last quarter. Avitas Wealth Management LLC raised its holdings in Invesco Dynamic Biotechnology & Genome ETF by 59.3% in the 3rd quarter. Avitas Wealth Management LLC now owns 6,568 shares of the company’s stock valued at $311,000 after acquiring an additional 2,444 shares in the last quarter. Finally, Investment House LLC raised its holdings in Invesco Dynamic Biotechnology & Genome ETF by 85.9% in the 2nd quarter. Investment House LLC now owns 9,200 shares of the company’s stock valued at $492,000 after acquiring an additional 4,250 shares in the last quarter.

NYSEARCA PBE traded up $1.25 during midday trading on Friday, hitting $51.68. The company had a trading volume of 29,386 shares, compared to its average volume of 16,878. Invesco Dynamic Biotechnology & Genome ETF has a twelve month low of $43.17 and a twelve month high of $56.65. The firm has a 50-day moving average price of $49.12 and a 200-day moving average price of $50.78.

Invesco Dynamic Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Want to see what other hedge funds are holding PBE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE).

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.